|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
O'Connell JB, Maggard MA and Ko CY: Colon
cancer survival rates with the new American joint committee on
cancer sixth edition staging. J Natl Cancer Inst. 96:1420–1425.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Collins JF, Lieberman DA, Durbin TE and
Weiss DG: Veterans Affairs Cooperative Study #380 Group: Accuracy
of screening for fecal occult blood on a single stool sample
obtained by digital rectal examination. A comparison with
recommended sampling practice. Ann Intern Med. 142:81–85. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Esquela-Kerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wiemer EA: The role of microRNAs in
cancer: N o small matter. Eur J Cancer. 43:1529–1544. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duttagupta R, Jiang R, Gollub J, Getts RC
and Jones KW: Impact of cellular miRNAs on circulating miRNA
biomarker signatures. PloS one. 6:e207692011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schetter AJ and Harris CC: Plasma
microRNAs: A potential biomarker for colorectal cancer? Gut.
58:1318–1319. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whiting P, Rutjes AW, Reitsma JB, Bossuyt
PM and Kleijnen J: The development of QUADAS, A tool for the
quality assessment of studies of diagnostic accuracy included in
systematic reviews. BMC Med Res Methodol. 3:252003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Reitsma JB, Glas AS, Rutjes AW, Scholten
RJ, Bossuyt PM and Zwinderman AH: Bivariate analysis of sensitivity
and specificity produces informative summary measures in diagnostic
reviews. J Clin Epidemiol. 58:982–990. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rutter CM and Gatsonis CA: A hierarchical
regression approach to meta-analysis of diagnostic test accuracy
evaluations. Stat Med. 20:2865–2884. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Moses LE, Shapiro D and Littenberg B:
Combining independent studies of a diagnostic test into a summary
ROC curve, Data-analytic approaches and some additional
considerations. Stat Med. 12:1293–1316. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dinnes J, Deeks J, Kirby J and Roderick P:
A methodological review of how heterogeneity has been examined in
systematic reviews of diagnostic test accuracy. Health Technol
Assess. 9(iii): 1–113. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zamora J, Abraira V, Muriel A, Khan K and
Coomarasamy A: Meta-DiSc: A software for meta-analysis of test
accuracy data. BMC Med Res Methodol. 6:312006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Basati G, Razavi Emami A, Abdi S and
Mirzaei A: Elevated level of microRNA-21 in the serum of patients
with colorectal cancer. Medical Oncol. 31:2052014. View Article : Google Scholar
|
|
20
|
Wang B and Zhang Q: The expression and
clinical significance of circulating microRNA-21 in serum of five
solid tumors. J Cancer Res Clin Oncol. 138:1659–1666. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu GH, Zhou ZG, Chen R, Wang MJ, Zhou B,
Li Y and Sun XF: Serum miR-21 and miR-92a as biomarkers in the
diagnosis and prognosis of colorectal cancer. Tumour Biol.
34:2175–2181. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogata-Kawata H, Izumiya M, Kurioka D,
Honma Y, Yamada Y, Furuta K, Gunji T, Ohta H, Okamoto H, Sonoda H,
et al: Circulating exosomal microRNAs as biomarkers of colon
cancer. PloS one. 9:e929212014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo X, Stock C, Burwinkel B and Brenner H:
Identification and evaluation of plasma microRNAs for early
detection of colorectal cancer. PloS One. 8:e628802013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Toiyama Y, Takahashi M, Hur K, Nagasaka T,
Tanaka K, Inoue Y, Kusunoki M, Boland CR and Goel A: Serum miR-21
as a diagnostic and prognostic biomarker in colorectal cancer. J
Natl Cancer Inst. 105:849–859. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanaan Z, Rai SN, Eichenberger MR, Roberts
H, Keskey B, Pan J and Galandiuk S: Plasma miR-21: A potential
diagnostic marker of colorectal cancer. Ann Surg. 256:544–551.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang H, Li P, Ju H, Pesta M, Kulda V, Jin
W, Cai M, Liu C, Wu H, Xu J, et al: Diagnostic and prognostic value
of micro RNA-21 in colorectal cancer: An original study and
individual participant data meta-analysis. Cancer Epidemiol
Biomarkers Prev. 23:2783–2792. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du M, Liu S, Gu D, Wang Q, Zhu L, Kang M,
Shi D, Chu H, Tong N, Chen J, et al: Clinical potential role of
circulating microRNAs in early diagnosis of colorectal cancer
patients. Carcinogenesis. 35:2723–2730. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rosenfeld RM and Shiffman RN: Clinical
practice guidelines: A manual for developing evidence-based
guidelines to facilitate performance measurement and quality
improvement. Otolaryngol Head Neck Surg. 135((Suppl 4)): S1–S28.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Selcuklu SD, Donoghue MT and Spillane C:
miR-21 as a key regulator of oncogenic processes. Biochem Soc
Trans. 37:918–925. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeng Z, Wang J, Zhao L, Hu P, Zhang H,
Tang X, He D, Tang S and Zeng Z: Potential role of microRNA-21 in
the diagnosis of gastric cancer, A meta-analysis. PloS One.
8:e732782013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang X, Guo Y, Du Y, Yang J, Li S, Liu S,
Li K and Zhang D: Serum microRNA-21 as a diagnostic marker for lung
carcinoma, A systematic review and meta-analysis. PloS One.
9:e974602014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krichevsky AM and Gabriely G: miR-21: A
small multi-faceted RNA. J Cell Mol Med. 13:39–53. 2009. View Article : Google Scholar : PubMed/NCBI
|
